Do you want to read an article? Please log in or register.
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung Disease
Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Bintalib HM, van de Ven AAJM, Rojas-Reyes MX, Davidsen JR, Hanitsch LG, Cinetto F, Malphettes M, Van Montfrans JM, Jacob J, Milito C, Haerynck F, Strauss F, Cool C, Calderon-Jaramillo M, Lopez-Mujica X, Maglione P, Trujillo-Martin MM, ESID Clinical Guideline Working Party; ERS e-GLILDnet Clinical Research Collaboration, Fevang B, Routes J, Hurst JR, Warnatz K
doi: 10.1183/13993003.02224-2025
COMMENTED
Interstitial Lung Disease
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM
doi: 10.1183/13993003.02533-2024
RECOMMENDED
Interstitial Lung DiseasePneumonia
Inflammatory activity as a predictor of clinical deterioration in interstitial pneumonia with autoimmune features: a comparative cohort study with connective tissue disease-associated interstitial lung disease
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Ulutaş F, Yiğit N, Güngör G, Çobankara V
doi: 10.1177/17534666261465583
Pulmonary Fibrosis
The Role of ETI Therapy in Managing Sinusitis in Cystic Fibrosis pediatric population: A Study on Clinical Outcomes
Respir Med
Terracciano R, Cerchione R, Cimbalo C, Buonpensiero P, Di Pasqua A, De Rosa E, Di Salle F, Castaldo A, Capasso F, Tosco A, Cantone E, Sepe A
doi: 10.1016/j.rmed.2026.109065
Interstitial Lung Disease
An Update to the Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy: An Official American Thoracic Society Clinical Practice Guideline
Am J Respir Crit Care Med
McGraw MD, DeBoer E, Weinman JP, Deutsch GH, Pogoriler J, Parenti MB, Kurland G, Blatter J, Casey AM, Deterding RR, Fiorino EK, Young LR, Barnes H, Balasubramaniam V, Brennan SK, Charoenpong P, Craven D, Dell S, Epaud R, Fishman MP, Gettys A, Goldfarb S, Gower WA, Ha DM, Hagood JS, Hamvas A, Jaffe A, Kennedy JC, Krivchenia K, Liptzin DR, Nathan N, Nevel RJ, Ocasio-Ramirez V, Pryhuber G, Raby BA, Sadreameli SC, Teper A, Vargas SO, Vece TJ, Iyer NP, Nogee LM, Wambach JA, American Thoracic Society Assembly on Pediatrics
doi: 10.1093/ajrccm/aamag375
Lung Cancer
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)
Lung Cancer
Borghetti P, D'Angelillo R, Facheris G, Borghesi A, Bruni A, Ceruti P, Ferrari K, Filippi AR, Ramella S, Signorelli D, Pappagallo G, Ricardi U, Collaborators
doi: 10.1016/j.lungcan.2025.108807
RECOMMENDED
Interstitial Lung Disease
Clinical utility of lung biopsy in fibrotic interstitial lung disease
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Mor E, Piciucchi S, Ravaglia C, Aronson K, Poletti V, Hariri LP, Khor YH, Churg A, Collins B, Fabre A, Adegunsoye A, Chung J, Cooper WA, Cottin V, Dotan Y, Hague C, Inoue Y, Jacob J, Martinez F, Podolanczuk AJ, Tomassetti S, Wells AU, Wijsenbeek MS, Yasufuku K, Dominy L, Mcdonald J, Sangari S, Ryerson CJ
doi: 10.1093/ajrccm/aamaf123
Interstitial Lung DiseaseFurther Publications
The importance of considering progression speed in systemic sclerosis-associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study
Respir Res
Roeser A, Brillet PY, Tran Ba S, Caux F, Dhote R, Nunes H, Uzunhan Y
doi: 10.1186/s12931-025-03375-7
Further Publications
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies
Lancet Respir Med
Burgel PR, Da Silva J, Girodon E, Durieu I, Reynaud-Gaubert M, Murris-Espin M, Chiron R, Grenet D, Ramel S, Mely L, Hamidfar R, Douvry B, Houdouin V, Audousset C, Macey J, Mittaine M, Weiss L, Cosson L, Danner-Boucher I, Reix P, Baravalle M, Burnet E, Sermet-Gaudelus I, Martin C, Paillasseur JL, French Cystic Fibrosis Reference Network study group
doi: 10.1016/S2213-2600(25)00190-0